Cepsa Tower, the company's new corporate headquarters that houses almost 2,000 people, is Spain's second tallest building and represents the materialization of Cepsa's growth and internationalization strategy of in recent years, following the entry of International Petroleum Investment Company (IPIC), as sole shareholder.
The headquarters, designed by the architect Norman Foster, reflects the transformation of Cepsa's business model to focus on an increasingly international market. Its height, at 248 metres, provides a unique view of Madrid from its upper floors, taking in some of the city's most emblematic locations such as the Paseo de la Castellana, the Parque del Retiro and the Santiago Bernabéu stadium.
Cepsa today operates an integrated business model spanning the entire hydrocarbon value chain. This integration allows the company to act with greater flexibility and the ability to respond quickly as a business.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7703451-cepsa-new-headquarters-new-company/
Cepsa Tower, the company's new corporate headquarters that houses almost 2,000 people, is Spain's second tallest building and represents the materialization of Cepsa's growth and internationalization strategy of in recent years, following the entry of International Petroleum Investment Company (IPIC), as sole shareholder.
The headquarters, designed by the architect Norman Foster, reflects the transformation of Cepsa's business model to focus on an increasingly international market. Its height, at 248 metres, provides a unique view of Madrid from its upper floors, taking in some of the city's most emblematic locations such as the Paseo de la Castellana, the Parque del Retiro and the Santiago Bernabéu stadium.
Cepsa today operates an integrated business model spanning the entire hydrocarbon value chain. This integration allows the company to act with greater flexibility and the ability to respond quickly as a business.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7703451-cepsa-new-headquarters-new-company/
At Munich’s real estate exhibition last week, Russia’s leading e-commerce company, Ulmart, hosted a “working breakfast” to discuss the nuances and intricacies of investing in Russia today during times of heightened international tension.
The topic, “Making the Case for Star Investment Projects in Russia”, featured Ulmart’s chairman and majority shareholder Dmitry Kostygin; Andrew Kaye, Managing Director and Co-Head of Technology Banking, William Blair International; Calin Anton Business Development Director Russia & CIS, Astron; and, Tim Millard, Regional Director, Head of Consulting Services at Jones Lang LaSalle, Russia.
A lively discussion kicked off about how some in the investment community tend to focus—even obsess—on macro realties at a state-to-state level ignoring many truly interesting project; precisely the types of projects that keep most of the world’s economies developing positively from cycle to cycle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7660751-ulmart-russian-investment-update/
At Munich’s real estate exhibition last week, Russia’s leading e-commerce company, Ulmart, hosted a “working breakfast” to discuss the nuances and intricacies of investing in Russia today during times of heightened international tension.
The topic, “Making the Case for Star Investment Projects in Russia”, featured Ulmart’s chairman and majority shareholder Dmitry Kostygin; Andrew Kaye, Managing Director and Co-Head of Technology Banking, William Blair International; Calin Anton Business Development Director Russia & CIS, Astron; and, Tim Millard, Regional Director, Head of Consulting Services at Jones Lang LaSalle, Russia.
A lively discussion kicked off about how some in the investment community tend to focus—even obsess—on macro realties at a state-to-state level ignoring many truly interesting project; precisely the types of projects that keep most of the world’s economies developing positively from cycle to cycle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7660751-ulmart-russian-investment-update/
Sullivan & Cromwell announces the launch of a multi-part video series designed to share insights from senior S&C lawyers on trends and issues impacting global financial institutions. The interviews are conducted by Lee Pacchia, Founder and CEO of Mimesis Law. In the first segment, Mitch Eitel, Managing Partner of the S&C Financial Services Group, discusses the appearance of shareholder activism in the sector, the psychology that affects the industry and burdens on financial institutions from a range of Dodd Frank changes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7542531-sullivan-cromwell/
At the end of the year and as we approach PR Newswire’s 60th anniversary in March, there is a natural inclination to reflect. At PR Newswire, we are just as interested in looking forward to the future for communicators of all kinds – PR, corporate, marketing and shareholder – and their audiences. While technology continues to evolve and new communication channels continue to emerge, everyone at PR Newswire remains focused on helping brands and organizations earn targeted attention from consumers, investors and the media by amplifying our clients’ narratives and making their content more discoverable.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/64514-happy-new-year-from-pr-newswire-2014
AbbVie (NYSE:ABBV) today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
With a rich, 125-year heritage of developing pharmaceuticals, AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. A global enterprise that serves patients in more than 170 countries, AbbVie launches with an estimated $18 billion in annual revenues and a strong commitment to creating shareholder value through long-term growth potential and the continuation of the company’s history of shareholder dividends.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59757-abbvie-celebrates-launch-as-new-biopharmaceutical-company
